Sponsors (2)
The bill increases transparency and oversight of royalties and conflicts of interest—strengthening public trust and allowing better detection of problematic financial ties—at the cost of greater privacy exposure for individuals and added administrative and compliance burdens for agencies, experts, and contractors.
Taxpayers and the public gain much greater transparency because advisory‑committee members, inventors, and covered individuals will have royalty and waiver information recorded and reported, helping reveal potential conflicts of interest and improving trust in federal science and public‑health advice.
Federal agencies and Congress will be better able to detect and address conflicts of interest tied to royalty payments from contractors and grantees, improving procurement integrity and reducing the risk that financial interests distort government-funded research or contracting decisions.
Routine GAO listings and required annual agency reports create public records and consistent data flows that enable accountability, oversight, and policymakers to identify systemic problems and pursue targeted fixes.
Federal employees, scientists, and inventors face privacy and personal‑safety risks because names and royalty amounts will be published online and confidential disclosures will be broadly shared with Members of Congress with limited redactions, increasing exposure to targeted harassment or misuse of sensitive data.
Agencies and advisory‑committee members will face increased administrative and compliance burdens from expanded disclosure and reporting requirements, raising operational costs and consuming staff time that could otherwise be used on program work.
Government contractors and grantees must incur additional compliance costs to disclose royalty payments and related information, increasing overhead for entities that receive federal funds.
Based on analysis of 4 sections of legislative text.
Expands financial-disclosure and waiver reporting for certain public-health advisory committee members, adds royalty checks to contractor COI reviews, and mandates annual agency reporting.
Official title: To require executive branch employees to report certain royalties, and for other purposes.
Introduced March 5, 2025 by H. Morgan Griffith · Last progress March 5, 2025
Expands transparency and conflict-of-interest checks across the executive branch by requiring additional public-health advisory committee members to file financial-disclosure reports, tightening and accelerating congressional notice when ethics waivers are granted, and making federal conflict-of-interest reviews for prospective contractors and grantees explicitly check for royalty payments from the prior year. Agencies must submit annual reports to oversight and authorizing committees (and intelligence committees where applicable) about royalty-related potential COIs and mitigation actions. The bill also directs GAO to publish and annually update a list of covered advisory committees for 5 years and includes a severability clause.